Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Agilent Technologies

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 31
Average round size
info
The average size of a deal this fund participated in
$24M
Portfolio companies 24
Rounds per year 1.24
Lead investments 4
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.23
Exits 7
Key employees 1

Areas of investment

  • Biotechnology
  • Health Care
  • Genetics
  • Manufacturing
  • Wireless
Summary

Agilent Technologies is the famous Corporate Investor, which was founded in 1999. The leading representative office of defined Corporate Investor is situated in the Santa Clara. The company was established in North America in United States.

The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Agilent Technologies, startups are often financed by StartX (Stanford-StartX Fund), Crosspoint Venture Partners, Celtic House Venture Partners. The meaningful sponsors for the fund in investment in the same round are iSELECT FUND, Redpoint, Moore Capital. In the next rounds fund is usually obtained by Redpoint, Sequoia Capital, Oak Investment Partners.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Among the most popular fund investment industries, there are Manufacturing, Wireless. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Gen9, Purigen Biosystems, Novera Optics.

Opposing the other organizations, this Agilent Technologies works on 18 percentage points more the average amount of lead investments. The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2000. Despite it in 2019 the fund had an activity. The higher amount of exits for fund were in 2002. Speaking about the real fund results, this Corporate Investor is 2 percentage points less often commits exit comparing to other organizations.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Agilent Technologies:
Typical Co-investors
Agilent Technologies is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Agilent Technologies:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Avoro Ventures -
Deqing Jingshi China, Deqing, Zhejiang
Emerging Ventures Seed Fund Kentucky, Owensboro, United States
GMAG Holdings Inc. Colorado, Denver, United States
Gungin Business Support Fund -
Jiangxi Guozi Chuangye Touzi Guanli China, Guangdong, Jiangxi
K2 Wind Foundation -
KISCO Japan, Osaka, Osaka Prefecture
Meadow Lane Investments Ohio, Reynoldsburg, United States
Nutshell Invest OU -
PCS Holding AG Frauenfeld, Switzerland, Thurgau
RES Investments Minnesota, Saint Paul, United States
TechOperators Atlanta, Georgia, United States
TGM ventures California, Santa Monica, United States
Twin Point Capital California, Palo Alto, United States
Viant California, Irvine, United States
Zhongding Financial Information Service China, Shanghai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Halo X Ray Technologies

Industrial Automation
Industrial Engineering
Machinery Manufacturing
$2M06 Sep 2023 Nottingham, England, United Kingdom

Halo Labs

Analytics
Biopharma
Biotechnology
Health Diagnostics
Pharmaceutical
$7M11 Jul 2022 Philadelphia, Pennsylvania, United States

Arima Genomics

Biotechnology
Health Care
Medical
$7M15 Mar 2022 San Diego, California, United States

PreciseDx

Health Care
$10M11 Jan 2022 New York, New York, United States

Nicoya Lifesciences

Biotechnology
Developer Platform
Nanotechnology
Sensor
$15M16 Dec 2021 Waterloo, Ontario, Canada

Akadeum Life Sciences

Biotechnology
Information Technology
Medical
$17M12 Oct 2021 Ann Arbor, Michigan, United States

Mobilion Systems

Biotechnology
Life Science
Therapeutics
$60M13 Jul 2021 Chadds Ford Township, Pennsylvania, United States

Molecular Assemblies

Biotechnology
Genetics
Health Care
$11M15 Apr 2021 San Diego, California, United States

Cardea Bio

Biotechnology
Information Technology
Manufacturing
Semiconductor
$7M17 Sep 2020 San Diego, California, United States
News
MOBILion Systems Raises $60M in Series C Funding

– MOBILion System from Chadds Fords develops high-resolution instrumentation for biomarker discovery.
– The company raised $60M in Series C funding.
– The round was led by D1 Capital Partners with participation from aMoon, Agilent Technologies, IP Group, Hostplus and Cultivation Capital.
– The new investment will be used to scale the commercialization of MOBIE® and advance product development for expansion into bioprocessing and multiomic biomarker discovery markets.

Molecular Assemblies Closes $24M Series A

– Molecular Assemblies is a private life sciences company developing an enzymatic DNA synthesis technology designed to power the next generation of DNA-based products.
– The company announced that it has closed an oversubscribed $24m Series A financing with significant investment from Agilent Technologies, iSelect Fund, Codexis, Alexandria Venture Investments, and Argonautic Ventures.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Agilent Technologies?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 31
Average round size 24M
Rounds per year 1.24
Peak activity year 2021
Lead investments 4
Follow on index 0.23
Exits 7
Group Appearance index 0.94

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Halo X Ray Technologies

Industrial Automation
Industrial Engineering
Machinery Manufacturing
$2M06 Sep 2023 Nottingham, England, United Kingdom

Halo Labs

Analytics
Biopharma
Biotechnology
Health Diagnostics
Pharmaceutical
$7M11 Jul 2022 Philadelphia, Pennsylvania, United States

Arima Genomics

Biotechnology
Health Care
Medical
$7M15 Mar 2022 San Diego, California, United States

PreciseDx

Health Care
$10M11 Jan 2022 New York, New York, United States

Nicoya Lifesciences

Biotechnology
Developer Platform
Nanotechnology
Sensor
$15M16 Dec 2021 Waterloo, Ontario, Canada

Akadeum Life Sciences

Biotechnology
Information Technology
Medical
$17M12 Oct 2021 Ann Arbor, Michigan, United States

Mobilion Systems

Biotechnology
Life Science
Therapeutics
$60M13 Jul 2021 Chadds Ford Township, Pennsylvania, United States

Molecular Assemblies

Biotechnology
Genetics
Health Care
$11M15 Apr 2021 San Diego, California, United States

Cardea Bio

Biotechnology
Information Technology
Manufacturing
Semiconductor
$7M17 Sep 2020 San Diego, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: